Abstract:Colon cancer, a prevalent malignant tumor affecting the digestive system, presents a substantial risk to human health due to its high occurrence and mortality rates. Phellinus baumii polyphenol (PBP), a natural product derived from traditional Chinese medicine, has gained widespread popularity due to its low toxicity and minimal side effects, compared to radiation and chemotherapy. This study used an integrated approach of network pharmacology and experimental verification to elucidate the anti-colon cancer effects of PBP and its potential mechanisms. In network pharmacology, the identification of relevant targets involved a comprehensive search across multiple databases using keywords such as "active components of PBP" and "colon cancer". Venn diagram analysis was subsequently performed to ascertain the shared targets. To identify the key active components and core targets, we constructed a network of "Disease-Drug-Pathways-Targets" and a protein-protein interaction (PPI) network among the targets using Cytoscape 3.9.1. Furthermore, molecular docking was carried out to predict the binding affinity and conformation between the main active compounds (davallialactone and citrinin) of PBP and the core targets (TP53, STAT3, CASP3, CTNNB1, PARP1, MYC). To validate our findings, in vitro experiments were conducted. We verified that PBP exerted an anti-colon cancer effect on human colon cancer HCT116 cells by significantly inhibiting cell proliferation, promoting apoptosis and arresting the cell cycle in S phase by using Cell Counting Kit-8 (CCK-8) and flow cytometry. Finally, we determined the key regulatory proteins related to apoptosis and the cell cycle by western blot analysis, and proposed the potential mechanism by which PBP exerts an anti-colon cancer effect by inducing the caspase-dependent mitochondrial-mediated intrinsic apoptotic pathway and arresting the cell cycle in S phase in HCT116 cells. These results suggest that PBP possesses substantial potential for the treatment of colon cancer and may serve as a viable alternative therapeutic strategy in colon cancer treatment.

The Research Progress of Polysaccharide of Phellinus

Recent advances in the bioactive polysaccharides and other key components from Phellinus spp. and their pharmacological effects: A review

Antitumor and Immunomodulation Activities of Polysaccharide from Phellinus Baumii.

Recent Advances in Extraction and Isolation of Plant Polysaccharides

Phellinus linteus polysaccharides: A review on their preparation, structure-activity relationships, and drug delivery systems

Research Progress on the Antitumor Effect of Polysaccharides from Fungus Used in Traditional Chinese Medicine

Polysaccharides from Phellinus linteus: A systematic review of their extractions, purifications, structures and functions

Research Progress on the Anticancer Activity of Plant Polysaccharides

<i>Phellinus baumii</i> Polyphenol: A Potential Therapeutic Candidate against Lung Cancer Cells

Pharmacologically enhanced visualization of esophageal varices by Pro-Banthine.

The structural characterization of a polysaccharide exhibiting antitumor effect from Pholiota adiposa mycelia

Elucidation of the Anti-Colon Cancer Mechanism of Phellinus Baumii Polyphenol by an Integrative Approach of Network Pharmacology and Experimental Verification.

[Progress on Antineoplastic Constituents Derived from Polypore Fungi].

A hematogenous spread brain abscess invading the right damaged temporomandibular joint.

Polysaccharides as Potential Anti-tumor Biomacromolecules —A Review

Brachiopods from Eniwetok and Bikini Drill Holes

Tumor Microenvironment as a New Target for Tumor Immunotherapy of Polysaccharides

Advances on Bioactive Polysaccharides from Medicinal Plants

Study on Extraction, Physicochemical Properties, and Bacterio-Static Activity of Polysaccharides from Phellinus linteus

Coffee and hypokalemia.

Polysaccharides from fungi: A review on their extraction, purification, structural features, and biological activities